4-(methylthio)-3-butenyl isothiocyanate has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdull Razis, AF; Ibrahim, MD; Ioannides, C; Iori, R; Kntayya, SB; Mohd Ain, N | 1 |
| Inoue, T; Ishii, Y; Matsuo, T; Nakamura, Y; Nishikawa, A; Ogawa, K; Okamoto, S; Okamura, T; Park, EY; Sato, K; Tasaki, M; Umemura, T | 1 |
2 other study(ies) available for 4-(methylthio)-3-butenyl isothiocyanate and Adenocarcinoma
| Article | Year |
|---|---|
Induction of Apoptosis and Cytotoxicity by Raphasatin in Human Breast Adenocarcinoma MCF-7 Cells.
Topics: Adenocarcinoma; Apoptosis; Breast Neoplasms; Cytotoxins; Female; G2 Phase Cell Cycle Checkpoints; Humans; Isothiocyanates; M Phase Cell Cycle Checkpoints; MCF-7 Cells | 2018 |
Chemopreventive effects of 4-methylthio-3-butenyl Isothiocyanate (Raphasatin) but not curcumin against pancreatic carcinogenesis in hamsters.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Carcinogens; Cricetinae; Curcumin; Diet; Hyperplasia; Isothiocyanates; Male; Mesocricetus; Nitrosamines; Pancreas; Pancreatic Neoplasms | 2013 |